2512 Is there a difference in outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) who receive chemotherapy (CT) vs androgen receptor-targeted therapy (ART) after 1st-line ART in the community setting?
Year: 2015
Type: article
Source: European Journal of Cancer
Authors: W.K. Oh, R. Miao, F. Vekeman, J. Sung, W.Y. Cheng, M. Gauthier-Loiselle, J. Fortier, R. Dhawan, D. Hennessy, M.S. Duh
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2515872486